FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, particularly to drug substance - deanole aceglumate. Solid dosage drug formulation of deanole aceglumate is proposed, that is suitable for manufacturing of capsules and tablets; it contains ingredients as follows: 2-(dimethylamino)ethanol, N-acetyl-L-glutamic acid, cellulose derivatives, calcium carbonate, colloid silicon dioxide, starch, talcum, magnesium stearate, sweetener, aromatiser, and aminoacetic acid.
EFFECT: stable solid dosage drug formulation of deanole aceglumate is developed.
2 cl, 6 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DEANOL ACEGLUMATE DEMONSTRATING ANTIULCEROGENIC, GASTROPROTECTIVE AND ENTEROPROTECTIVE ACTIVITY, COMBINATION POSSESSING ANTIULCEROGENIC, GASTROPROTECTIVE AND ENTEROPROTECTIVE ACTIVITY (VERSIONS), PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2435575C2 |
| INJECTION DRUG FORMULATION WITH NEUROPROTECTIVE PROPERTIES | 2006 |
|
RU2331414C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIINFLAMMATORY, BRONCHOLYTIC, ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2448961C1 |
| STABLE PHARMACEUTICAL COMPOSITION OF ANTIHYPERTENSIVE ACTION | 2007 |
|
RU2341254C1 |
| COMBINED POLYVITAMIN COMPOSITION AND METHOD FOR ITS PREPARING | 2004 |
|
RU2282442C2 |
| SOLID DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING COMBINATION OF VILDAGLIPTIN AND GLIQUIDONE | 2014 |
|
RU2585378C1 |
| COMBINED REMEDY FOR IMPROVING THE FUNCTIONAL STATE OF THE BRAIN | 2021 |
|
RU2782672C1 |
| PHARMACEUTICAL COMPOSITIONS BASED ON 9-BUTYLAMINO-3,3-DIMETHYL-3,4-DIHYDROACRIDINE-1(2H)-ONE HYDROCHLORIDE FOR THE CORRECTION OF COGNITIVE AND NEUROLOGICAL DISORDERS | 2015 |
|
RU2664439C2 |
| PHARMACEUTICAL COMPOSITION WITH ANTI-DIARRHEA EFFECT | 2004 |
|
RU2276979C2 |
| SOLID DOSED FORMULATION FOR TREATMENT OF PANCREATIC DIABETES | 2006 |
|
RU2333760C2 |
